Dashboard
Manage Tickers

TYRA Tyra Biosciences, Inc.

Nasdaq tyra.bio


$ 14.24 $ 0.13 (0.93 %)    

Thursday, 23-Oct-2025 16:01:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 14.12
$ 13.92
$ 6.77 x 1
$ 15.40 x 50
$ 13.75 - $ 14.23
$ 6.42 - $ 29.60
152,218
na
752.56M
$ 2.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-19-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

raymond-james-initiates-coverage-on-tyra-biosciences-with-strong-buy-rating-announces-price-target-of-35
Raymond James Initiates Coverage On Tyra B...
09/03/2025 16:54:11

Raymond James analyst Chris Raymond initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Strong Buy rating and announ...

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
08/22/2025 10:58:16

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 pr...

tyra-biosciences-doses-first-child-in-phase-2-trial-of-dabogratinib-first-oral-fgfr3-inhibitor-for-achondroplasia
Tyra Biosciences Doses First Child In Phas...
08/21/2025 12:12:26

-Dabogratinib is the only oral FGFR3-selective inhibitor in clinical development for achondroplasia--Initial results from safet...

tyra-biosciences-q2-eps-047-beats-053-estimate
Tyra Biosciences Q2 EPS $(0.47) Beats $(0....
08/14/2025 20:37:16

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0....

tyra-biosciences-says-late-breaking-abstract-on-tyra-300-preclinical-results-accepted-for-presentation-at-endo-2025
Tyra Biosciences Says Late-Breaking Abstra...
07/08/2025 20:09:45

Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision me...

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
07/01/2025 11:37:22

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price...

piper-sandler-assumes-tyra-biosciences-at-overweight-announces-price-target-of-33
Piper Sandler Assumes Tyra Biosciences at ...
05/21/2025 15:05:58

Piper Sandler analyst Allison Bratzel assumes Tyra Biosciences (NASDAQ:TYRA) with a Overweight rating and announces Price Ta...

tyra-biosciences-q1-eps-047-beats-048-estimate
Tyra Biosciences Q1 EPS $(0.47) Beats $(0....
05/08/2025 20:53:36

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0....

northrop-grumman-posts-downbeat-results-joins-halliburton-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Northrop Grumman Posts Downbeat Results, J...
04/22/2025 12:08:37

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
04/22/2025 12:06:53

why-calix-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why Calix Shares Are Trading Higher By 13%...
04/22/2025 09:30:49

why-wafd-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket
Why WaFd Shares Are Trading Higher By 6%; ...
04/14/2025 09:31:29

why-penguin-solutions-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Penguin Solutions Shares Are Trading H...
04/03/2025 09:27:37

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
03/31/2025 11:16:34

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price...

tyra-biosciences-q4-2024-gaap-eps-043-beats-047-estimate
Tyra Biosciences Q4 2024 GAAP EPS $(0.43) ...
03/27/2025 20:19:42

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0....

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
02/18/2025 11:56:02

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price...

hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Tyra...
01/13/2025 12:02:30

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price...

tyra-biosciences-receives-ind-clearance-from-the-fda-to-proceed-with-a-phase-2-study-of-tyra-300-in-non-muscle-invasive-bladder-cancer
Tyra Biosciences Receives IND Clearance Fr...
01/10/2025 13:09:10

ubs-initiates-coverage-on-tyra-biosciences-with-buy-rating-announces-price-target-of-28
UBS Initiates Coverage On Tyra Biosciences...
01/07/2025 12:44:31

UBS analyst Eliana Merle initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target o...

neumora-therapeutics-xpeng-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Neumora Therapeutics, XPeng And Other Big ...
01/02/2025 13:30:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION